|Legal Status||To be confirmed|
An antidepressant which acts as a pre-synaptic alpha2-antagonist, which increases central noradrenergic and serotinergic neurotransmission. It also acts as an H1 histamine antagonist; this accounts for its sedative effects which are prominent in overdose.
|Short Term Effects||
The most common effect following ingestion is sedation. Other features may include nausea, vomiting, headache, tremor, miosis, disorientation, ataxia, tachycardia, bradycardia and hypotension. Rhabdomyolysis has been reported. Effects on the central nervous system may be enhanced or prolonged following co-ingestion of other central nervous system depressants, including alcohol.
Identified in Sweden: 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one (norfludiazepam). Norfludiazepam is a benzodiazepine and is structurally related to the internationally controlled substance diazepam.
WEDINOS Service upgrade…: Great news following Welsh Governments recent funding of the project until 2025, all our new analytical tools are in place. Our analysts have completed their training and familiarisation and will, over the next fortnight, be working through the backlog of samples generated as a result of this necessary pause in service. Normal testing and service turnaround times should resume at the beginning of June. We thank you for your continued support and patience.